Creating a defect in tRNA molecules could weaken bacteria’s two-pronged defense and help make faster-acting antibiotics
The vaccine proves safe in a small sample of human subjects, opening the way for the next phase of testing.
Gasdermin E could be a useful target for improving cancer therapy.
Researchers developed a novel recombinant vaccine called NIPRAB that shows robust immunization against Nipah virus in animal models and may be effective against other viruses in the same family.
New research lays foundation for upcoming clinical trial for patients with epidermolysis bullosa
To unravel programmed cell death pathways, investigators examine a molecule deemed unimportant, and find new function.
Jefferson researchers discover potential therapy for major disease symptom
For news not listed on this page view the Jefferson News Archive.